Skip to main content
SpringerLink
Log in

Linagliptin labels provide greater warnings of pancreatitis risk

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. See also this issue p3; 803090004

Reference

  • Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Announce Updates to Prescribing Information for TRADJENTA (linagliptin) Tablets and JENTADUETO (linagliptin and metformin hydrochloride) Tablets. Media Release : 20 Jun 2013. Available from: URL: http://www.boehringer-ingelheim.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Linagliptin labels provide greater warnings of pancreatitis risk. Reactions Weekly 1461, 4 (2013). https://doi.org/10.1007/s40278-013-4527-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-4527-2

Search

Navigation